ArticleJournal of market access & health policy2026
Valuation of Medical Innovation in Orphan Diseases with a Focus on Small Investors and Limited Diversifiable Risks.
Mark Nuijten et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.